Key fact: The joint European monitoring report recorded 110 HPAI A(H5N1) detections in birds during its summer observation period: seven in domestic birds and 103 in wild birds, across 12 countries. Joint scientific report
Read the summer result in its proper time window
The joint EFSA, ECDC and European reference laboratory report describes European bird-flu detections as remaining at a seasonal low during summer. Its journal edition appeared on 30 September 2026. The bird observations end in August; they are not a statement of October conditions at a particular source. Joint scientific report
Our commercial interpretation is to use this interval for preparation rather than assume unrestricted autumn cover. A regional monitoring result cannot establish the status of a contracted lot, processing plant or destination route. Buyers should distinguish three questions: what the surveillance report observed, what the responsible authorities currently require and what the supplier can actually deliver.
Make the autumn review about the source chain
EFSA and the European Commission's September prevention campaign explicitly addresses autumn migration. Its practical farm measures include controlling access, cleaning and disinfection, preventing contact with wild birds, separating poultry species and recognising disease early. These are farm-biosecurity measures, not a certification scheme for rendered ingredients. EFSA campaign announcement, 17 September 2026
For procurement, we recommend asking how the proposed ingredient's source chain is identified and how changes are communicated. Record the raw-material species and origin separately from the processing establishment and dispatch location. A warehouse address alone should not be used to fill all three fields. Where a supplier sources across several areas, ask which origins are assigned to the offer and whether substitution requires the buyer's consent.
Agree what information triggers a fresh review. That might include a change of establishment, raw-material origin, production date or documentary route. Do not convert a supplier's general biosecurity statement into evidence about a specific lot. Keep the evidence and its scope visible so the technical and commercial teams are discussing the same material.
Separate disease monitoring from processing assurance
The Commission's animal-by-product framework is built around safe sourcing, safe treatment and safe end uses, with traceability and risk-based controls. That provides the existing regulatory context for ingredient qualification. Commission overview of EU animal-by-product rules
Our recommended qualification file should identify the establishment, relevant approval or registration, selected product category and processing route. Ask the competent technical reviewer which evidence is needed for the offered material and intended use. Do not rely on the word rendered as a complete description of a treatment, or invent a universal temperature and time requirement for all poultry ingredients.
Equally, do not imply that a detection in wild birds demonstrates contamination of a finished meal. The surveillance finding and the product assessment answer different questions. Any decision to accept, hold or reject a lot should refer to its applicable requirements and evidence, not to an unsupported inference from a disease headline.
Verify the destination before booking the shipment
As a commercial control, have the responsible compliance specialist confirm the rules applicable to the actual product, origin, establishment and destination at the relevant time. Identify the certificate or declaration required for that route and who will supply it. Record the source used for the check and the review date rather than retaining an undated statement that exports are allowed.
Avoid both extremes: a summer lull is not universal clearance, while a new outbreak notification is not proof of a blanket ban on every processed poultry ingredient. Where a restriction is reported, establish its product scope, geographical scope and timing through authoritative information. Keep unresolved questions outside the approved shipment file and ask for clarification before paying for freight or committing an advance.
Contract continuity without diluting the specification
We suggest separating physically allocated stock from future production in each offer. Ask which quantity is ready, which depends on processing and what delivery window is genuinely committed. For a recurring programme, agree a notification deadline for source changes and a review process for alternative material. Do not treat a promise of a similar protein percentage as approval for a replacement grade.
Keep poultry meal, hydrolysed feather meal and a poultry blood-meal grade as distinct technical enquiries. Retain the agreed protein, fat, ash, moisture and digestibility requirements where applicable, together with their analytical basis. The formulation team should approve any substitute; the purchasing team should separately approve the revised price, packaging and logistics. Neither approval should be assumed from the other.
Keep one clear autumn readiness record
Our proposed readiness record has a named owner for source verification, processing evidence, destination checks and delivery confirmation. For each open shipment, retain the last completed review and the specific missing item. Label a pending authority clarification as pending rather than allowing it to disappear inside a general compliant status.
The objective is an actionable buying file, not a prediction of disease spread or ingredient prices. Use the summer findings to prepare questions, and use current product-specific evidence to answer them. A quieter monitoring period is most useful when it gives the buyer time to make the next shipment decision more precise.